Swedish Orphan Biovitrum AB (CHIX:SOBIs) Stock News, Headlines & Updates
Swedish Orphan Biovitrum AB Stock News from GuruFocus
- 1
Jul 01, 2025
Sobi to amend existing agreement with Apellis for ex-U.S. royalties of Aspaveli® (systemic pegcetacoplan)
PRNewswire • 7:00am
Jun 28, 2025
FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still's disease
PRNewswire • 7:00pm
Apr 30, 2025
Swedish Orphan Biovitrum AB (BIOVF) Q1 2025 Earnings Call Highlights: Strong Haematology Growth Amid Immunology Challenges
GuruFocus News • 1:12am
Q1 2025 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript
GuruFocus News • 11:04pm
Apr 29, 2025
Sobi publishes Q1 2025 report: Portfolio continues to deliver
PRNewswire • 2:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news